Cognizant Total Revenue increased by 1.5% to $5.41B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $5.12B to $5.41B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 3.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.59B | $4.74B | $4.78B | $4.83B | $4.91B | $4.86B | $4.84B | $4.81B | $4.89B | $4.90B | $4.76B | $4.76B | $4.85B | $5.04B | $5.08B | $5.12B | $5.25B | $5.42B | $5.33B | $5.41B |
| QoQ Change | — | +3.5% | +0.7% | +1.0% | +1.7% | -1.0% | -0.4% | -0.6% | +1.5% | +0.2% | -2.8% | +0.0% | +1.9% | +4.0% | +0.8% | +0.6% | +2.5% | +3.2% | -1.5% | +1.5% |
| YoY Change | — | — | — | — | +7.0% | +2.4% | +1.3% | -0.3% | -0.4% | +0.8% | -1.7% | -1.1% | -0.7% | +3.0% | +6.8% | +7.5% | +8.1% | +7.4% | +4.9% | +5.8% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Consulting And Technology Services | $3.07B | $3.23B | $3.24B | $3.23B | $3.39B | $3.49B | $3.42B | $3.49B |
| Outsourcing Services | $1.78B | $1.82B | $1.85B | $1.89B | $1.86B | $1.92B | $1.91B | $1.92B |
| Total | $4.85B | $5.04B | $5.08B | $5.12B | $5.25B | $5.42B | $5.33B | $5.41B |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Financial Services | $1.45B | $1.49B | $1.44B | $1.46B | $1.55B | $1.58B | $1.59B | $1.64B |
| Healthcare Segment | $1.46B | $1.51B | $1.54B | $1.57B | $1.55B | $1.60B | $1.62B | $1.58B |
| Products and Resources | $1.13B | $1.23B | $1.30B | $1.28B | $1.31B | $1.38B | $1.32B | $1.32B |
| Communications, Media and Technology | $817.25M | $817.25M | $817.25M | $804.00M | — | — | — | $869.00M |
| Communication, Media and Technology | $816.00M | $816.00M | — | $804.00M | $841.00M | $850.00M | — | — |
| Total | $4.85B | $5.04B | $5.08B | $5.12B | $5.25B | $5.42B | $5.33B | $5.41B |
Communication, Media and Technology was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| North America | $3.62B | $3.74B | $3.82B | $3.85B | $3.91B | $4.03B | $3.99B | $4.05B |
| Europe | $914.00M | $967.00M | $939.00M | $950.00M | $1.00B | $1.04B | $1.02B | $1.04B |
| Europe, excluding United Kingdom | $470.00M | $485.00M | $494.00M | $493.00M | $520.00M | $539.00M | $538.00M | $530.00M |
| Rest of World | $316.00M | $342.00M | $321.00M | $311.00M | $331.00M | $345.00M | $329.00M | $322.00M |
| Total | $4.85B | $5.04B | $5.08B | $5.12B | $5.25B | $5.42B | $5.33B | $5.41B |